The Liver Unit, Department of Gastroenterology, Tel Aviv Sourasky Medical Center, 64239 Tel-Aviv, Israel.
World J Gastroenterol. 2011 Aug 7;17(29):3377-89. doi: 10.3748/wjg.v17.i29.3377.
Nonalcoholic fatty liver disease (NAFLD) has been recognized as a major health burden. The high prevalence of NAFLD is probably due to the contemporary epidemics of obesity, unhealthy dietary pattern, and sedentary lifestyle. The efficacy and safety profile of pharmacotherapy in the treatment of NAFLD remains uncertain and obesity is strongly associated with hepatic steatosis; therefore, the first line of treatment is lifestyle modification. The usual management of NAFLD includes gradual weight reduction and increased physical activity (PA) leading to an improvement in serum liver enzymes, reduced hepatic fatty infiltration, and, in some cases, a reduced degree of hepatic inflammation and fibrosis. Nutrition has been demonstrated to be associated with NAFLD and Non-alcoholic steatohepatitis (NASH) in both animals and humans, and thus serves as a major route of prevention and treatment. However, most human studies are observational and retrospective, allowing limited inference about causal associations. Large prospective studies and clinical trials are now needed to establish a causal relationship. Based on available data, patients should optimally achieve a 5%-10% weight reduction. Setting realistic goals is essential for long-term successful lifestyle modification and more effort must be devoted to informing NAFLD patients of the health benefits of even a modest weight reduction. Furthermore, all NAFLD patients, whether obese or of normal weight, should be informed that a healthy diet has benefits beyond weight reduction. They should be advised to reduce saturated/trans fat and increase polyunsaturated fat, with special emphasize on omega-3 fatty acids. They should reduce added sugar to its minimum, try to avoid soft drinks containing sugar, including fruit juices that contain a lot of fructose, and increase their fiber intake. For the heavy meat eaters, especially those of red and processed meats, less meat and increased fish intake should be recommended. Minimizing fast food intake will also help maintain a healthy diet. PA should be integrated into behavioral therapy in NAFLD, as even small gains in PA and fitness may have significant health benefits. Potentially therapeutic dietary supplements are vitamin E and vitamin D, but both warrant further research. Unbalanced nutrition is not only strongly associated with NAFLD, but is also a risk factor that a large portion of the population is exposed to. Therefore, it is important to identify dietary patterns that will serve as modifiable risk factors for the prevention of NAFLD and its complications.
非酒精性脂肪性肝病(NAFLD)已被认为是一个主要的健康负担。NAFLD 的高患病率可能是由于肥胖、不健康的饮食模式和久坐不动的生活方式的当代流行。药物治疗治疗 NAFLD 的疗效和安全性仍不确定,肥胖与肝脂肪变性密切相关;因此,一线治疗是生活方式的改变。NAFLD 的常规治疗包括逐渐减轻体重和增加体力活动(PA),从而改善血清肝酶、减少肝脂肪浸润,在某些情况下,减少肝炎症和纤维化的程度。营养已被证明与动物和人类的非酒精性脂肪性肝病(NASH)有关,因此是主要的预防和治疗途径。然而,大多数人类研究都是观察性和回顾性的,这使得对因果关系的推断非常有限。现在需要进行大型前瞻性研究和临床试验来建立因果关系。基于现有数据,患者应最佳地实现 5%-10%的体重减轻。设定现实的目标对于长期成功的生活方式改变至关重要,必须更加努力地告知 NAFLD 患者即使适度减轻体重也能带来健康益处。此外,所有 NAFLD 患者,无论肥胖还是体重正常,都应被告知健康饮食除了减轻体重之外还有其他好处。应建议他们减少饱和/反式脂肪并增加多不饱和脂肪,特别强调ω-3 脂肪酸。他们应该将添加的糖减少到最低限度,尽量避免含糖的软饮料,包括含有大量果糖的果汁,并增加膳食纤维的摄入量。对于爱吃肉的人,尤其是红肉和加工肉,应建议减少肉类摄入并增加鱼类摄入。减少快餐摄入也有助于保持健康饮食。PA 应纳入 NAFLD 的行为治疗中,因为即使 PA 和健康方面的微小收益也可能具有显著的健康益处。潜在的治疗性膳食补充剂是维生素 E 和维生素 D,但两者都需要进一步研究。营养失衡不仅与 NAFLD 密切相关,而且还是很大一部分人群面临的风险因素。因此,确定可作为预防 NAFLD 及其并发症的可改变危险因素的饮食模式非常重要。